Health
J&J says late-stage COVID-19 vaccine trial fully enrolled – Reuters
Johnson & Johnson said on Thursday it has fully enrolled participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate.
By Reuters Staff
Dec 17 (Reuters) – Johnson & Johnson said on Thursday it has fully enrolled participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate.
The study, named Ensemble, has enrolled about 45,000 participants and is being conducted by its unit Janssen, J&J said here in a statement, adding that it expects interim data from the trial by the end of January 2021.
J&J also said it plans to submit an emergency use authorization application to the U.S. Food and…
-
Noosa News20 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News24 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Business21 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
General13 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people